Загрузка...
Epoetin alfa decreases the number of red blood cell transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt’s leukemia/lymphoma—results of a randomized clinical trial
PURPOSE: Anemia is an expected consequence of intensive chemotherapy regimens administered to acute leukemia patients. This study was designed to determine if epoetin alfa would decrease the number of transfusion events and units of packed red blood cells (PRBCs) transfused, and secondarily, to stud...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3919032/ https://ncbi.nlm.nih.gov/pubmed/21751205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26341 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|